Li Li, Secretary of the Party Leadership Group of the China Food and Drug Administration: Exploring the Application of "Blockchain" and Other Technologies to Strengthen Credit Governance of Supervised Objects

The Secretary of the Party Leadership Group and Deputy Director of the Drug Administration Bureau of the Lili Information Center pointed out during the investigation that a new platform must be used to build a new structure, the regulatory department must use a smart regulatory platform to clear the information barriers in all links, and use products to trace the platform to the entire life cycle Data integration. It is necessary to use new technologies to enhance new efficiency, use information technology, especially big data, artificial intelligence technology, etc. to explore "off-site supervision" of production enterprises, and strengthen the supervision of "two products and one machine" for online sales through "ruling the Internet with the Internet" , Exploring the application of "blockchain" and other technologies to strengthen the credit governance of regulatory objects.